Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin.
作者信息
Freund K B, Shah S A, Shah V P
出版信息
Eye (Lond). 2013 Jun;27(6):773-4. doi: 10.1038/eye.2013.94. Epub 2013 May 3.
Abstract
摘要
相似文献
1
Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin.玻璃体内注射奥克纤溶酶后短暂视力丧失与外层视网膜破坏的相关性
Eye (Lond). 2013 Jun;27(6):773-4. doi: 10.1038/eye.2013.94. Epub 2013 May 3.
2
Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography.玻璃体内注射 ocriplasmin 后视力丧失：频域光相干断层扫描和视网膜电图的相关性。
JAMA Ophthalmol. 2014 Apr 1;132(4):487-90. doi: 10.1001/jamaophthalmol.2013.8258.
3
Safety and complications of ocriplasmin: ocriplasmin, ocriplasmin; oh, how safe art thou?奥克纤溶酶的安全性与并发症：奥克纤溶酶，奥克纤溶酶；噢，你究竟有多安全？
JAMA Ophthalmol. 2014 Apr 1;132(4):379-80. doi: 10.1001/jamaophthalmol.2014.278.
4
Early panretinal abnormalities on fundus autofluorescence and spectral domain optical coherence tomography after intravitreal ocriplasmin.玻璃体内注射奥克纤溶酶后眼底自发荧光和光谱域光学相干断层扫描早期全视网膜异常。
Acta Ophthalmol. 2016 Mar;94(2):e160-2. doi: 10.1111/aos.12749. Epub 2015 May 24.
5
Sterile endophthalmitis after intravitreal ocriplasmin injection: report of a single case.玻璃体内注射奥克纤溶酶后发生的无菌性眼内炎：一例报告。
Retin Cases Brief Rep. 2015 Summer;9(3):242-4. doi: 10.1097/ICB.0000000000000149.
6
WIDESPREAD MACULAR NEUROSENSORY DETACHMENT AFTER OCRIPLASMIN INTRAVITREAL INJECTION.玻璃体内注射奥克裂纤酶后广泛的黄斑神经感觉层脱离
Retin Cases Brief Rep. 2016 Fall;10(4):354-6. doi: 10.1097/ICB.0000000000000260.
7
PERSISTENT RETINAL CHANGES AFTER INTRAVITREAL OCRIPLASMIN.玻璃体内注射奥克纤溶酶后的持续性视网膜改变
Retin Cases Brief Rep. 2016 Winter;10(1):48-51. doi: 10.1097/ICB.0000000000000175.
8
Assessment of retinal alterations after intravitreal ocriplasmin with spectral-domain optical coherence tomography.采用频域光学相干断层扫描评估玻璃体内注射奥克纤溶酶后的视网膜改变。
Ophthalmology. 2014 Dec;121(12):2506-2507.e2. doi: 10.1016/j.ophtha.2014.07.044. Epub 2014 Sep 7.
9
Zonular Dehiscence at the Time of Combined Vitrectomy and Cataract Surgery After Intravitreal Ocriplasmin Injection.玻璃体内注射奥克纤溶酶后玻璃体切割联合白内障手术时的晶状体悬韧带断裂
JAMA Ophthalmol. 2015 Sep;133(9):1091-2. doi: 10.1001/jamaophthalmol.2015.1680.
10
Reversible vision loss and outer retinal abnormalities after intravitreal ocriplasmin injection.玻璃体内注射奥克纤溶酶后出现可逆性视力丧失和视网膜外层异常。
Retin Cases Brief Rep. 2014 Fall;8(4):330-2. doi: 10.1097/ICB.0000000000000061.
引用本文的文献
1
Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵引后的视觉功能变化：微视野分析
Taiwan J Ophthalmol. 2020 Dec 4;11(3):259-265. doi: 10.4103/tjo.tjo_57_20. eCollection 2021 Jul-Sep.
2
Assessment of Expression System for Overexpression of Active Recombinant Ocriplasmin.活性重组奥克纤溶酶过表达表达系统的评估
Adv Pharm Bull. 2021 May;11(3):564-569. doi: 10.34172/apb.2021.065. Epub 2020 Jun 21.
3
Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study).玻璃体内注射奥克纤溶酶治疗后椭圆体带完整性的回顾性研究（臭氧研究）
Clin Ophthalmol. 2021 Jul 16;15:3109-3120. doi: 10.2147/OPTH.S285464. eCollection 2021.
4
Post hoc analysis of ellipsoid zone changes beyond the central subfield in symptomatic vitreomacular adhesion patients from the OASIS trial.来自OASIS试验的有症状玻璃体黄斑粘连患者中央子区域以外的椭圆体带变化的事后分析。
BMJ Open Ophthalmol. 2021 Jun 21;6(1):e000648. doi: 10.1136/bmjophth-2020-000648. eCollection 2021.
5
Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH.伴或不伴黄斑裂孔的玻璃体黄斑牵引的全氟化丙烷玻璃体气融术：DRCR 视网膜网络协议 AG 和 AH。
Ophthalmology. 2021 Nov;128(11):1592-1603. doi: 10.1016/j.ophtha.2021.05.005. Epub 2021 May 12.
6
Italian real-life experience on the use of ocriplasmin.意大利使用奥克纤溶酶的真实生活经验。
BMJ Open Ophthalmol. 2018 Aug 10;3(1):e000110. doi: 10.1136/bmjophth-2017-000110. eCollection 2018.
7
Pneumatic Vitreolysis for Management of Symptomatic Focal Vitreomacular Traction.用于治疗症状性局限性玻璃体黄斑牵引的气体性玻璃体溶解术
J Ophthalmic Vis Res. 2017 Oct-Dec;12(4):419-423. doi: 10.4103/jovr.jovr_146_17.
8
PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION.用于缓解玻璃体黄斑牵引的气体性玻璃体溶解术
Retina. 2017 Oct;37(10):1820-1831. doi: 10.1097/IAE.0000000000001448.
9
Ocriplasmin for Treatment of Vitreomacular Traction: An Update.玻璃体内注射奥克纤溶酶治疗玻璃体黄斑牵拉：最新进展
Ophthalmol Ther. 2016 Dec;5(2):147-159. doi: 10.1007/s40123-016-0062-6. Epub 2016 Sep 12.
10
[Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes (≤400 μm) compared to tranconjunctival vitrectomy].与经结膜玻璃体切除术相比，使用奥克纤溶酶进行药理玻璃体溶解术作为有症状的局灶性玻璃体黄斑牵引伴或不伴黄斑裂孔（≤400μm）的一种治疗选择
Ophthalmologe. 2017 Feb;114(2):148-154. doi: 10.1007/s00347-016-0322-9.
本文引用的文献
1
Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes.用 ocriplasmin 进行酶玻璃体溶解治疗玻璃体黄斑牵引和黄斑裂孔。
N Engl J Med. 2012 Aug 16;367(7):606-15. doi: 10.1056/NEJMoa1110823.
Zotero 插件